ReachMD

Dr. Susan Goodin is the director of the division of pharmaceutical sciences at the Cancer Institute of New Jersey in New Brunswick, and an associate professor of medicine in the division of medical oncology at the University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School in New Brunswick. She is also an adjunct associate professor of pharmacy practice and administration at Rutgers University College of Pharmacy in Piscataway, New Jersey, as well as co-director of the Symptom Management–Supportive Care Group at the Cancer Institute of New Jersey.

After earning her doctorate in pharmacy from the University of Kentucky College of Pharmacy in Lexington, Dr. Goodin completed a pharmacy practice residency at the University of Kentucky Medical Center, and an oncology pharmacy residency at the Lucille P. Markey Cancer Center in conjunction with the University of Kentucky Medical Center. Dr. Goodin is a board-certified oncology pharmacist and was elected a fellow of the American College of Clinical Pharmacy in October 2006.

Dr. Goodin is a member of several professional societies, including the American Society of Health-System Pharmacists, for which she is the immediate past-chair for the ASHP Section of Clinical Specialists and Scientists, the American College of Clinical Pharmacy, the American Society of Clinical Oncologists, the Hematology Oncology Pharmacy Association, and the International Society of Oncology Pharmacy Practice, for which she is the U.S. delegate and a member of the research committee. She is currently the vice chair of the Oncology Specialty Council of the Board of Pharmaceutical Specialties. An active clinician and researcher, she has given many presentations throughout the United States, Canada, and Europe, and her work has appeared in journals such as the American Journal of Health-System Pharmacy, Clinical Cancer Research, The Journal of Clinical Oncology, The Journal of the American Pharmacy Association, and Cancer.